Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

News | Ultrasound Intra-cardiac Echo (ICE)

September 20, 2017 — Catheter ablation to treat an irregular heartbeat, which limits or eliminates patients’ exposure to ...

Home September 20, 2017
Home
LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.
Feature | Left Atrial Appendage (LAA) Occluders

September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to ...

Home September 07, 2017
Home
News | Atrial Fibrillation

September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with ...

Home September 01, 2017
Home
News | Atrial Fibrillation

September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause ...

Home September 01, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

August 28, 2017 — Bristol-Myers Squibb Company and Pfizer Inc. announced results from an analysis of real-world data ...

Home August 28, 2017
Home
News

August 7, 2017 — CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three ...

Home August 07, 2017
Home
News | Atrial Fibrillation

Aug. 2, 2017 — A new health economic analysis from the landmark FIRE and ICE Trial was published this week in the ...

Home August 02, 2017
Home
News | Atrial Fibrillation

Aug. 1, 2017 — The Japanese Ministry of Health, Labour and Welfare has granted Japanese market clearance for the ...

Home August 01, 2017
Home
News

July 24, 2017 — Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will ...

Home July 24, 2017
Home
News | Atrial Fibrillation

July 12, 2017 — Cardiac Insight Inc., a U.S. developer of wearable medical devices and diagnostic software, announced ...

Home July 12, 2017
Home
News | Atrial Fibrillation

July 3, 2017 — Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation ...

Home July 03, 2017
Home
News | Stroke

June 28, 2017 — Newly diagnosed asymptomatic atrial fibrillation patients have a higher rate of previous stroke than ...

Home June 28, 2017
Home
Biosense webster multi-electrode balloon RF ablation catheter. The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 
Feature | EP Lab | Dave Fornell

Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve ...

Home June 22, 2017
Home
News | Atrial Fibrillation

May 30, 2017 — Data was positive for safety and efficacy rates of the Watchman Left Atrial Appendage Closure (LAAC) ...

Home May 30, 2017
Home
News

May 30, 2017 — Abbott recently announced European CE mark and first use of the new Confirm Rx Insertable Cardiac Monitor ...

Home May 30, 2017
Home
Subscribe Now